1E Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AUGM-101 / 1E Therap
NCT04964141: In This Study AUGM-101 Will be Assessed for Its Safety, Tolerability, Pharmacokinetic and Pharmacodynamic in Healthy Volunteers and COVID-19-infected Patients

Recruiting
1/2
104
RoW
AUGM-101, Placebo
1E Therapeutics
Covid19
04/22
05/22

Download Options